Lv7
4670 积分 2021-03-04 加入
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Nanoparticle-mediated dual targeting of stromal and immune components to overcome fibrotic and immunosuppressive barriers in hepatocellular carcinoma
2个月前
已完结
Targeting γ-aminobutyric acid via potassium-chelating and zinc-releasing ionic modulation to suppress spinal metastasis of lung cancer
2个月前
已关闭
Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis
2个月前
已完结
Furmonertinib activity in NSCLC Harbouring EGFR L858R and ERBB2 S310F co-mutations: a case report with literature review
4个月前
已完结
NIR‐Responsive Fe3O4@MSN@PPy‐PVP Nanoparticles as the Nano‐Enzyme for Potential Tumor Therapy
8个月前
已完结
Bioresponsive Controlled Drug Release Based on Mesoporous Silica Nanoparticles Coated with Reductively Sheddable Polymer Shell
8个月前
已完结
One-Pot Synthesized Mesoporous Silica Nanoparticles Loaded with Chlorfenapyr for Effective Control of Plutella xylostella
8个月前
已关闭
Smart Mesoporous Silica Nanoparticles Loading Curcumin Inhibit Liver Cancer
8个月前
已完结
Layer-by-layer construction of lipid bilayer on mesoporous silica nanoparticle to improve its water suspensibility and hemocompatibility
8个月前
已完结
皖公网安备34019202002308
